QUOTE AND NEWS
SeekingAlpha  Apr 16  Comment 
By Bay Area Biotech Investor: Corcept Therapeutics (CORT) is a $368M (as of 4/14/2014) pharmaceutical company located in Menlo Park, CA, with 44 employees. Doctors Joseph Belanoff and Alan Schatzberg co-founded Corcept in 1998. Dr. Belanoff...
StreetInsider.com  Apr 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Corcept+Therapeutics+%28CORT%29+Enters+Manf.+Agreement+with+AAIPharma/9374322.html for the full story.
DailyFinance  Apr 2  Comment 
MENLO PARK, CA and THE WOODLANDS, TX -- (Marketwired) -- 04/02/14 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe...
StreetInsider.com  Mar 28  Comment 
The following is a list of notable articles to help get you through the lunch hour: Tesla (TSLA) CEO Elon Musk in the National Spotlight -> Read this! Corcept (CORT) Moves Above Key Level to New 52-Week High -> Read this! Mannkind (MNKD)...
Benzinga  Mar 10  Comment 
In a report published Monday, Stifel analyst Annabel Samimy terminated coverage on Corcept Therapeutics (NASDAQ: CORT). In the report, Stifel noted, “Due to a reallocation of resources, we are discontinuing coverage of Corcept Therapeutics....
StreetInsider.com  Mar 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Corcept+Therapeutics%2C+Inc.+%28CORT%29+Posts+Q4+Loss+of+11cShare/9248359.html for the full story.
SeekingAlpha  Jan 31  Comment 
Corcept Therapeutics Incorporated (CORT) Sales Trading Statement Conference Call January 30, 2014 5:00 PM ET Executives Charles Robb – Chief Financial Officer Joseph K. Belanoff – President and Chief Executive Officer ...
DailyFinance  Jan 30  Comment 
MENLO PARK, CA -- (Marketwired) -- 01/30/14 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) Fourth quarter 2013 revenue up 56% over third quarter 2013 revenueCompany anticipates Korlym 2014 revenue to grow to a range of $24 million to $28...
Benzinga  Jan 13  Comment 
In a report published Monday, Stifel analyst Annabel Samimy downgraded Corcept Therapeutics Incorporated (NASDAQ: CORT) to Hold. According to the report, CORT is making gradual progress with its Korlym (mifepristone) launch. However, 1.5 years...
StreetInsider.com  Nov 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Corcept+Therapeutics%2C+Inc.+%28CORT%29+Posts+Q3+Loss+of+8cShare/8861671.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki